CompletedNot Applicable

Study Evaluating the Treatment of Occipital Neuralgia

United States26 participantsStarted 2012-10

Plain-language summary

A proof of concept study to evaluate the feasibility of safe and effective treatment through optimization of the Cryo-Touch III device for temporary relief of or reduction in pain due to occipital neuralgia.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Male or female, 18 years of age and older. Female subjects of childbearing potential must not be pregnant at time of treatment.
. A confirmed diagnosis of occipital neuralgia (unilateral or bilateral) .
. Any medication must be maintained on a stable schedule for at least two weeks prior to treatment. No washout period is allowed.
. Must have an average score for pain of ≥ 4/10 Visual Analog Scale (VAS) over the last 7 days.
. Subject is willing and able to give written informed consent and able to comply with study instructions.

Exclusion criteria

. Current diagnosis of fibromyalgia, chronic back pain, or chronic migraines.
. Any injections intended for pain relief or neuromodulation to the upper trunk or head within the last 3 months.
. History of a cerebrovascular accident (CVA), head trauma, stroke, or bone deformity.
. Patient who has severe pain for any reason other than occipital neuralgia.
. Any use of (i.e. oral, topical, inhaled and/or injected) anesthetics or steroids within the last 30 days.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

A Reduction in Either Pain Frequency or Severity Associated With Occipital Neuralgia.

Timeframe: Baseline to Day 7, Baseline to Day 30

Trial details

NCT IDNCT01753765

SponsorPacira Pharmaceuticals, Inc

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-12

Results submitted2023-05-03

View on ClinicalTrials.gov More Occipital Neuralgia trials